Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NAK,,,Thanks,,,I am out ...Nice gain,,,nicer profit.
Well,,,two things that could be remembered. You have to remember there was a lot of wine and the conversation took place in Colorado,,,so,,,you know,,,it was late ,,,,lot of wine , gummys' and pipes,,,and well you know...
MPT,,,Not sure if Fitz can reply this week,,,he left for vacation but I am sure he will get internet somewhere,,,sometime. I thought I would just let you know.
$NAK,,,I hope you were able to pick up $.10 on this, I dumped 1/2 but I am an idiot
$TROV, I hope you didn't get into this. It never got the legs it needed.
Yep, Fitz always finds the companies to invest and hold for some great gains. Me, I will grab green when a stock gives it to me. I miss a lot of profit but then I miss a lot of retracement. Anyway, lots of ways to trade. Good luck always.
$NAK,,, it just looked so good the other day.
Right now I am sitting in my kayak fishing. Caught 3 snapper a grouper and a flounder. About to head in as I hear thunder and the sky looks troublesome. I will buy some crab and see if I can't talk someone into cooking and a little dancing this evening. I love my life!!!
$NAK,,, nice move and expecting more with some news hopefully.
$TROV,,,sorry but I am on my cell and can't type why. Check the chart
That scenario would be great, however, it's only one of a thousand which may happen. A good one that I would love to see happen.
Have fun Fitz. I will have to be out of pocket for a few days myself it looks like.
My stock picks haven't done so well,,,yet!
Go to a bait and tackle store and tell them you want a rattle weight/sinker. There is a company who has come out with those and they work great. The sound drives the stripped bass to it.
Should top $.004 today. In my opinion. I also believe we will hear something else,,,today. IMO.
Hey, throw all that rubbish out about the RSI, MFI and MacD outthe window
$ONCI,,,Ford moves meeting with ONCI (Soon to become Hexagon Holdings) up 5 weeks from original meeting date.
FORD FLEET SERVICES INVITES ON4 COMMUNICATIONS TO PRESENT ITS FMS SAFE DRIVING APP
New York, New York--(Marketwired –AUG 15 2017 – On4 Communications, Inc. (OTC Pink: (OTC :ONCI) today announced it has been invited to present its FMS Safe Driving App to Ford Fleet Services this coming Tuesday Aug 22 in California.
CEO Steve Berman states “After scheduling our Sept 27 meeting with Ford we received a call from Ford Fleet Services to present our FMS Safe Driving App on Tuesday Aug 22 in California. Ford fleet services sells to large corporations multi use vehicles including Sedans, Suv’s and Vans. They sell over 3 million cars per year.
“Ford fleet Services while under the umbrella of Ford is a completely separate company from Ford consumer division. Ford fleet Services only sells to large corporations.”
“In addition I will be travelling to San Antonio this Thursday Aug 17 to visit with the mayors office to discuss how to implement our FMS Safe Driving App into all city owned vehicles including Police, Fire Dept, Sanitation, correctional and all other city vehicles.
“After a successfully testing of our FMS Safe Driving app these last 2 weeks and a successful meeting by phone I have been invited to meet them in person this Thursday in San Antonio. “
We are very excited to have a second meeting with both entities and look forward to announcing more updates this week CEO Steve Berman Concludes.
I hope your weather, company and roads are all good. Enjoy your time!
Yeah, up $.10 before market opens. All the indicators show a good day head.
I hope you can't. Dig deeper into your pockets!!!
Looking at the 6-month chart as you are, I does show RSI, MFI, MacD and slow Stochastic needing a bit of a breather. While I do look at the 12-6-3-1 month charts, I will typically trade on how the 1 week (or 5-day) chart is set up. If you pull the 5-day chart you will immediately notice a big change from the 6-month chart. RSI is at 41.21 and headed in a downward direction. MFI is at 67.84 and also headed in a downward direction. The MacD is below the signal indicator headed in a downward direction. Slow Stochastic shows the k line at 75 and above the d line at 61, headed up.
My take is that unless positive news comes out, we will see a slight pullback in the price, however once we start getting some volume back in, the stock will again head upward. Ebb and Flow. Makes the pps what it is.
$AUPH,,,Just sitting up looking at some stocks while watching American Greed,
$AUPH,,,Another stock who had a great day and like AVEO, went up $.12. The stock closed at $6.17 after climbing up to a high of $6.25 during the day. RSI is at 40.99,,,MFI is at 31.42,,but both of these are heading slightly down for now. The MacD is just a hair under 0.00 and tilting ready to head up. The Slow Stochastic just turned up and the k has just crossed over the d. I like this for after the bell. Give it some time for money to flow into the stock. Just my opinion,
BioPharm Update,,,this is typically a weekly update on BioPharm upcoming trial dates. Sometimes fascinating to watch the pps move relevant to this list as the dates get closer to trial disclosure time.
Trial failures for Regeneron (REGN) Zynerba (ZYNE) Ophthotech (OPHT); CEL-SCI (CVM) clinical hold lifted
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) shares closed down 9% to $6.42 following its release that top line data from its Phase 2 STOP trial of ZYN002 (cannabidiol gel) for the treatment of osteoarthritis did not meet its primary endpoint. However, the company still intends to initiate a Phase 3 trial following promising data from secondary endpoints.
CEL-SCI Corporation (NYSE: CVM) noted that the FDA has removed the clinical hold on the Phase 3 cancer trial of Multikine. A partial clinical hold was announced September 2016 with a full clinical hold noted May 2017. Shares spiked to close up 30% to $3.00.
Omeros Corporation (NASDAQ: OMER) announced that it has commenced a registered underwritten public offering of 3m shares of its common stock.
Amarin Corporation plc (NASDAQ:AMRN) announced that the independent data monitoring committee (DMC) recommended that its REDUCE-IT cardiovascular outcomes trial continue as planned without modification. Data are expected in Q2 or Q3 2018.
Lipocine Inc. (NASDAQ:LPCN) received a PDUFA date of February 8, 2018 from the FDA for the resubmission of its NDA for TLANDO, for testosterone replacement therapy (TRT) in adult males. The company was issued a Complete Response Letter (CRL) in June 2016.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that its Phase 3 trial of suptavumab (REGN2222), an antibody to respiratory syncytial virus (RSV), did not meet its primary endpoint. The company plans to discontinue further clinical development.
Ophthotech Corporation (Nasdaq:OPHT) announced that it did not meet the primary endpoint in its third Phase 3 trial of Fovista for the treatment of wet age-related macular degeneration (AMD). The company had previously indicated a low likelihood of success given the failure of two previous trials.
Other major price movers (stocks priced > $1.00, volume > 100k):
Refer to the BioPharmCatalyst Biotech Stocks page for Top 10 Gainers/Losers/Unusual Volume INCLUDING sub-$1 stocks.
ADVANCERS:
Dova Pharmaceuticals Inc (NASDAQ:DOVA): $21.81; +20%.
Marinus Pharmaceuticals Inc (NASDAQ:MRNS): $2.83; +17%.
Anavex Life Sciences Corp. (NASDAQ:AVXL): $4.10; +14%.
Theravance Biopharma Inc (NASDAQ:TBPH): $27.48; +14%.
Soligenix, Inc. (NASDAQ:SNGX): $2.32; +14%.
DECLINERS:
KemPharm Inc (NASDAQ:KMPH): $2.75; -14%.
Lantheus Holdings Inc (NASDAQ:LNTH): $17.15; -10%.
Eleven Biotherapeutics Inc (NASDAQ:EBIO): $1.32; -9%.
Arca Biopharma Inc (NASDAQ:ABIO): $1.33; -9%.
Achieve Life Sciences Inc (NASDAQ:ACHV): $3.09; -7%.
Pipeline updates below:
DRUG STAGE CATALYST
TICKER: ACST
CaPre
Hypertriglyceridemia
PHASE 3 Phase 3 to be initiated 2H 2017.
TICKER: AMRN
Vascepa REDUCE-IT outcomes trial
High Triglycerides With Mixed Dyslipidemia
– Interim analysis announced September 12, 2016 - trial to proceed. Second interim analysis August 14, 2017 also recommended trial to continue. Final data due 2Q or 3Q 2018.
TICKER: CNAT
Emricasan
NASH fibrosis - ENCORE-NF trial
PHASE 2 Phase 2 completion of enrollment noted August 14, 2017. Data are due 1H 2019.
TICKER: CVM
Multikine
Head and Neck cancer
PHASE 3 Initiated Dec 2010. Announced partial clinical hold September 27, 2016. Full clinical hold noted May 2017. Clinical hold released - August 14, 2017.
TICKER: EBIO
Vicinium
Non-muscle invasive bladder cancer (NMIBC)
PHASE 3 Phase 3 enrollment to be completed 1Q 2018, with 3-month top-line data due mid-2018 and 12-month data due 2Q 2019.
TICKER: FATE
ProHema - PROTECT
Acute graft-versus-host disease (GvHD) undergoing hematopoietic cell transplantation (HCT)
PHASE 1/2 Phase 2 efficacy part of trial to be initiated September 2017.
TICKER: GTXI
Enobosarm
Breast cancer - advanced AR+ TNBC
PHASE 2 Noted August 14, 2017 that trial will not continue due to insufficient clinical benefit response (CBR).
TICKER: LPCN
LPCN 1021
Men with low testosterone (Low T)
PDUFA CRL issued June 2016. NDA resubmitted with new PDUFA February 8, 2017.
TICKER: OPHT
Fovista
Wet age-related macular degeneration (Wet-AMD)
PHASE 3 Phase 3 data released December 12, 2016 - primary endpoint not met. Data from third trial released August 14, 2017- primary endpoint not met.
TICKER: MBRX
Annamycin
Acute myeloid leukemia (AML) - cancer
PHASE 1/2 Phase 1/2 data due 2018.
TICKER: REGN
REGN2222
Respiratory syncytial virus (RSV)
PHASE 3 Phase 3 data released August 14, 2017 - primary endpoint not met.
TICKER: RETA
Omaveloxolone - MOXIe
Friedreich’s ataxia (FA)
PHASE 2 Phase 2 initial data released June 1, 2017. Primary endpoint not met. Part 2 due to be enroll 2H 2017.
TICKER: SPPI
QAPZOLA - Apaziquone
Bladder cancer
CRL Failed to meet primary endpoint in Phase 3 trial - Apr 2012. PDUFA date December 11 2016. Advisory Committee Meeting September 14 2016 voted 14 - 0 against approval. CRL issued November 17, 2016. New Phase 3 trial initiation announced August 14, 2017.
TICKER: TNXP
TNX-102 SL
Post-traumatic stress disorder (PTSD)
PHASE 3 Initiation of first of two Phase 3 trials announced March 28, 2017 in military-related PTSD 1Q 2017. Interim analysis due 1H 2018 with top-line data due 2H 2018.
TICKER: VBLT
VB-111
Recurrent glioblastoma (rGBM) cancer
PHASE 3 Phase 3 completion of enrollment announced January 6, 2017. Interim analysis due late September 2017. Top-line data due 1Q 2018.
TICKER: VBLT
VB-111
Recurrent platinum resistant ovarian cancer
PHASE 3 Phase 3 trial to be initiated by end of 2017.
TICKER: ZYNE
ZYN002 - STOP
Osteoarthritis
PHASE 2 Phase 2 data released August 14, 2017 - primary endpoint not met. However, company still intends to initiate Phase 3 trial pending discussions with FDA.
View in browser »
$AVEO,,,Had a great day yesterday and the pps rose to $3.30 before ending the day up $.19 to $3.10. After hours increased the pps to $3.12 @ 6:54pm. I think this stock will find legs again. The RSI is sitting at 36.52 headed up. The MFI is at 41.69 headed up. MacD is below 0 and appears to be heading up to cross the signal. Slow Stochastic the k is below the d at 13 and 15 with no where to go but up. As I have said, I love this stock and think it can rise $.10 - $.15 maybe more,,but if you know me,,,by that time I will be out.
$ONCI,,,Hopefully higher.
$ONCI,,,It was just a joke,,or a dream,,,nope, a joke
$ONCI,,,Really Randy?
$ONCI,,,No app,,,No Insurance. Period,,,World-Wide!
I wonder what the auction price might bring!
$NAK,,,$1.40,,,,everything is squeezed in and needs to pop soon.
$AVEO,,,All gone now. Very nice profit. I have been adding since the first of July. Long term for me.
$AVEO
$AEZS,,,Taking 50% Off the table @ $2.18
$AZEO,, Taking 50% off the table at $3.13
$ZAN,,,Need whole lotta love.
Wow Fitz,,,how do you really feel?,,,lol.
You were there much longer than me, thankfully. I never saw a post from David or Joe. I did have many with you and trust you did the right thing. Let's make this twice as good as on the other site!
$ONCI,,,Name Change,,,This might go to documents.
Filing Document with Colorado Secretary of State is up.
http://www.sos.state.co.us/biz/ViewImage.do?fileId=20171608394&masterFileId=20171608394
http://www.sos.state.co.us/biz/NameReservationDetail.do?quitButtonDestination=BusinessEntityResults&nameTyp=RSRV&entityId2=20171608394&srchTyp=MISC&masterFileId=20171608394
$ONCI,,,NAME CHANGE ,,,THIS WAS PROVIDED FRIDAY
Hexagon Holdings Corporation,,,,Colorado Filing
Filing Document with Colorado Secretary of State is up.
http://www.sos.state.co.us/biz/ViewImage.do?f...0171608394
http://www.sos.state.co.us/biz/NameReservatio...0171608394
Thanks, now if I can get back to it. Lol.
As it's my favorite, $AVEO,,,Should see a good day tomorrow and a nice week. Looking @ $3.15 as the next big resistance level.
$AUPH,, Looks really good and had a nice $.12 gain on Friday. Chart tells me this will continue. All my indicators look healthy to have a solid week.
Good luck trading and congratulations on getting this board started. Looking forward to a lot of advice from everyone so we can watch our accounts rise and provide us with all we need.
My apologies digger,,too many Sunday beers,,,you are correct,, oversold!
$ONCI,,,Had a great end of day 4.88M shares at 3:55. I am not sure where you see oversold but my chart shows RSI @ 23.40 headed up; MFI down to 3.47 & headed up; MacD about to cross the signal line; and slow stochastics just turning up giving a positive indication. Tomorrow should close the gap with no problem then continue up. All in my opinion. Good luck trading.
Thanks Iwanttomakemoneyy, very informative and concise. I appreciate that and agree with all of your requests.
$ONCI,,,Gotta love the Allman Brothers,,,and ONCI